Skip to main content
. Author manuscript; available in PMC: 2009 Sep 24.
Published in final edited form as: Ann Rheum Dis. 2007 Aug 2;67(4):478–484. doi: 10.1136/ard.2007.074104

Figure 3.

Figure 3

Haplotype combinations frequencies among ADA ACR50 responders and non responders at week 12. A. Comparison of the four main haplotypes of the TNF locus. B. Comparison of the GGC homozygous haplotype with all the other haplotypes. C. Comparison of the GGC homozygous haplotype with all the other haplotypes by treatment with ADA plus methotrexate (MTX), ADA plus any other disease-modifying antirheumatic drug (DMARD) or ADA alone (monotherapy).